This technology is currently not available for licensing
Tech ID: 29560
Additional Technologies by these Inventors
- Gene Editing of Monogenic Disorders in Human Hematopoietic Stem Cells
- Augmentations to Lentiviral Vectors to Increase Expression
- Improvement To Retroviral Vectors Containing The Human Ubiquitin C Promoter
- Generation Of Minimal Enhancer Elements Using Massively Parallel Reporter Assays
- Optimized Lentiviral Vector for Stem Cell Gene Therapy of Hemoglobinopathies
- Transient Expression Of BCL-2 To Ameliorate Cytotoxicity Of Gene Modification Reagents In Stem Cells
- Fusion Protein For Anti-Cd19 Chimeric Antigen Receptor Detection
